Literature DB >> 19514068

Clinical phenotype and neuroimaging findings in a French family with hereditary ferritinopathy (FTL498-499InsTC).

Fabienne Ory-Magne1, Christine Brefel-Courbon, Pierre Payoux, Sabrina Debruxelles, Igor Sibon, Cyril Goizet, Pierre Labauge, Patrice Menegon, Emmanuelle Uro-Coste, Bernardino Ghetti, Marie Bernadetle Delisle, Ruben Vidal, Olivier Rascol.   

Abstract

To describe a family with a hereditary ferritinopathy (HF) due to a mutation in the ferritin light chain gene (FTL498-499InsTC mutation). Case reports of the clinical features, MRI, (18)FDG PET, and pathological findings observed in this family with two patients described in more details. Postural tremor (phenotype-1) or cerebellar signs (phenotype-2) were the first neurological symptoms detected. Parkinsonian, cerebellar and pyramidal syndromes, abnormal involuntary movements, dementia were observed in both phenotypes at more advanced stages. Beside characteristics T2* hypointense signals suggestive of iron accumulation in the striatum, mesencephalon, and cerebellum, we detected more diffuse changes including cerebellar, cortical and subcortical atrophy, cortical iron deposition, and severe leukoencephalopathy. (18)FDG PET showed frontal and cerebellum hypometabolism with more severe frontal defect in patients with cognitive decline. Pathological examination showed ferritin and iron deposition in the liver, kidney, muscle, skin, and in the central nervous system. Members of this family affected by HF due to the FTL498-499InsTC mutation have a specific clinical presentation with initial postural tremor or cerebellar ataxia, followed by pyramidal and extrapyramidal motor syndromes and late severe subcortical dementia. 2009 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19514068     DOI: 10.1002/mds.22669

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  11 in total

1.  Accumulation of oxidative DNA damage in brain mitochondria in mouse model of hereditary ferritinopathy.

Authors:  Xiaoling Deng; Ruben Vidal; Ella W Englander
Journal:  Neurosci Lett       Date:  2010-05-15       Impact factor: 3.046

Review 2.  Pathogenic mechanism and modeling of neuroferritinopathy.

Authors:  Anna Cozzi; Paolo Santambrogio; Maddalena Ripamonti; Ermanna Rovida; Sonia Levi
Journal:  Cell Mol Life Sci       Date:  2021-01-13       Impact factor: 9.261

Review 3.  Cerebral Iron Deposition in Neurodegeneration.

Authors:  Petr Dusek; Tim Hofer; Jan Alexander; Per M Roos; Jan O Aaseth
Journal:  Biomolecules       Date:  2022-05-17

4.  Abnormal iron metabolism in fibroblasts from a patient with the neurodegenerative disease hereditary ferritinopathy.

Authors:  Ana G Barbeito; Thierry Levade; Marie B Delisle; Bernardino Ghetti; Ruben Vidal
Journal:  Mol Neurodegener       Date:  2010-11-10       Impact factor: 14.195

5.  A novel ferritin light chain mutation in neuroferritinopathy with an atypical presentation.

Authors:  Katsuya Nishida; Holly J Garringer; Naonobu Futamura; Itaru Funakawa; Kenji Jinnai; Ruben Vidal; Masaki Takao
Journal:  J Neurol Sci       Date:  2014-04-12       Impact factor: 3.181

6.  MRI findings in neuroferritinopathy.

Authors:  Emiko Ohta; Yoshihisa Takiyama
Journal:  Neurol Res Int       Date:  2011-07-21

7.  Abnormal iron homeostasis and neurodegeneration.

Authors:  Barry B Muhoberac; Ruben Vidal
Journal:  Front Aging Neurosci       Date:  2013-07-30       Impact factor: 5.750

Review 8.  Iron, Ferritin, Hereditary Ferritinopathy, and Neurodegeneration.

Authors:  Barry B Muhoberac; Ruben Vidal
Journal:  Front Neurosci       Date:  2019-12-11       Impact factor: 4.677

9.  Behavioral characterization of mouse models of neuroferritinopathy.

Authors:  Sara Capoccia; Federica Maccarinelli; Barbara Buffoli; Luigi F Rodella; Ottavio Cremona; Paolo Arosio; Francesca Cirulli
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

Review 10.  Neuroferritinopathy: Pathophysiology, Presentation, Differential Diagnoses and Management.

Authors:  Niraj Kumar; Philippe Rizek; Mandar Jog
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2016-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.